We are live on
!
Find out more
TD Asset Management Portfolio holdings
AUM
$123B
1-Year Est. Return
34.51%
This Fund
S&P 500
This Quarter
Est. Return
-15.11%
1 Year Est. Return
+34.51%
3 Year Est. Return
+98.94%
5 Year Est. Return
+122.3%
10 Year Est. Return
+375.56%
AUM
$86.3B
AUM Growth
-$23B
(-21%)
Cap. Flow
-$4.73B
Cap. Flow
% of AUM
-5.48%
Top 10 Holdings %
Top 10 Hldgs %
27.54%
Holding
1,537
New
55
Increased
353
Reduced
823
Closed
80
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$311M |
| 2 |
UnitedHealth
UNH
|
+$143M |
| 3 |
Stryker
SYK
|
+$139M |
| 4 |
Tesla
TSLA
|
+$133M |
| 5 |
Northrop Grumman
NOC
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.77B |
| 2 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$419M |
| 3 |
Meta Platforms (Facebook)
META
|
+$291M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$258M |
| 5 |
Comcast
CMCSA
|
+$154M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.12% |
| 2 | Technology | 17.73% |
| 3 | Healthcare | 10.68% |
| 4 | Consumer Discretionary | 8.18% |
| 5 | Communication Services | 8.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Stoke Therapeutics
STOK
$1.8B
| $459K | ﹤0.01% |
34,714
| – | – |
|
1302
Insteel Industries
IIIN
$593M
| $458K | ﹤0.01% |
13,600
+1,200
| +10% | +$47.7K |
|
|
DCBO
1303
Docebo
DCBO
$525M
| $452K | ﹤0.01% |
15,782
-23,646
| -60% | -$897K |
|
1304
First Financial Bankshares
FFIN
$5.04B
| $448K | ﹤0.01% |
+11,400
| New | +$467K |
|
1305
Nkarta
NKTX
$150M
| $441K | ﹤0.01% |
35,784
+8,590
| +32% | +$113K |
|
1306
Kornit Digital
KRNT
$705M
| $439K | ﹤0.01% |
13,862
+768
| +6% | +$40.6K |
|
1307
WaFd
WAFD
$2.72B
| $438K | ﹤0.01% |
+14,600
| New | +$458K |
|
1308
Teladoc Health
TDOC
$1.22B
| $436K | ﹤0.01% |
13,134
-10,277
| -44% | -$437K |
|
|
BLSA
1309
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
| $436K | ﹤0.01% |
44,047
| – | – |
|
1310
Lennox International
LII
$14.4B
| $435K | ﹤0.01% |
2,104
-470
| -18% | -$103K |
|
|
AVLR
1311
DELISTED
Avalara, Inc.
AVLR
| $432K | ﹤0.01% |
6,113
-200
| -3% | -$16.4K |
|
|
MORF
1312
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $430K | ﹤0.01% |
19,826
-5,511
| -22% | -$154K |
|
1313
Bentley Systems
BSY
$10.8B
| $429K | ﹤0.01% |
12,893
+200
| +2% | +$7.35K |
|
1314
M/I Homes
MHO
$3.74B
| $428K | ﹤0.01% |
+10,800
| New | +$469K |
|
|
THR
1315
DELISTED
Thermon Group Holdings
THR
| $428K | ﹤0.01% |
30,432
-2,064
| -6% | -$31.9K |
|
1316
Kodiak Sciences
KOD
$2.6B
| $427K | ﹤0.01% |
55,886
| – | – |
|
1317
C4 Therapeutics
CCCC
$385M
| $416K | ﹤0.01% |
55,153
-52,000
| -49% | -$458K |
|
1318
Dropbox
DBX
$7.6B
| $407K | ﹤0.01% |
19,408
-20,291
| -51% | -$439K |
|
1319
Alector
ALEC
$168M
| $405K | ﹤0.01% |
39,869
-19,988
| -33% | -$199K |
|
|
ROCC
1320
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $401K | ﹤0.01% |
+12,200
| New | +$459K |
|
|
CNTA
1321
DELISTED
Centessa Pharmaceuticals
CNTA
| $400K | ﹤0.01% |
82,055
+48,803
| +147% | +$312K |
|
1322
Metallus
MTUS
$838M
| $395K | ﹤0.01% |
+21,100
| New | +$448K |
|
|
IS
1323
DELISTED
ironSource Ltd.
IS
| $390K | ﹤0.01% |
163,700
| – | – |
|
1324
Shift4
FOUR
$4.2B
| $388K | ﹤0.01% |
11,724
-23,400
| -67% | -$1.1M |
|
1325
Ingredion
INGR
$6.27B
| $388K | ﹤0.01% |
4,400
+1,300
| +42% | +$116K |
|
Similar funds
VAM
TD Asset Management's Q2 2022 Portfolio in Review
As of Q2 2022, TD Asset Management held 1,537 positions worth $86.3B, down 21% from $109B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
TD Asset Management withdrew a net $4.73B in Q2 2022, closing 80 positions and reducing 823 holdings. Its most notable exit was Ortho Clinical Diagnostics Holdings plc Ordinary Shares, an estimated $23.8M position sold in full.
By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.
Against the trend, TD Asset Management opened a new position in Vanguard Short-Term Corporate Bond ETF worth $25M.
- TD Asset Management's largest Q2 2022 buy was Vanguard Short-Term Corporate Bond ETF: 327,600 shares worth $25M.
- TD Asset Management added most to iShares 20+ Year Treasury Bond ETF in Q2 2022, an estimated $311M increase.
- TD Asset Management's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.77B.
- TD Asset Management fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $23.8M.
- TD Asset Management's ten largest holdings make up 28% of its $86.3B portfolio in Q2 2022.
- TD Asset Management opened 55 new positions and closed 80 in Q2 2022.
- TD Asset Management's portfolio value fell 21% quarter-over-quarter to $86.3B.
Based on TD Asset Management's 13F filing for Q2 2022, filed 4 Aug 2022.